PHARMACOECONOMIC STUDY OF THE USE OF RITUXIMAB FOR SUBCUTANEOUS ADMINISTRATION IN THE TREATMENT OF FOLLICULAR LYMPHOMA

被引：0
|
作者：
Kulikov, A. [1 ]
Rybchenko, Y. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN190
引用
收藏
页码：A463 / A463
页数：1
相关论文
共 50 条
  • [21] Rituximab Maintenance in Follicular Lymphoma
    Barr, Paul M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (03) : 158 - 161
  • [22] Rituximab maintenance for follicular lymphoma
    Liat Vidal
    Anat Gafter-Gvili
    Ofer Shpilberg
    Nature Reviews Clinical Oncology, 2010, 7 : 1 - 1
  • [23] SAFETY OF SUBCUTANEOUS ADMINISTRATION OF RITUXIMAB DURING THE FIRST-LINE TREATMENT OF PATIENTS WITH NON-HODGKIN LYMPHOMA: THE MABRELLA STUDY
    Panizo, C.
    Bekadja, M. A.
    Meddeb, B.
    Meier, O.
    Smith, R.
    Truman, M.
    Barate, C.
    HAEMATOLOGICA, 2017, 102 : 252 - 253
  • [24] Rituximab in the Management of Follicular Lymphoma
    Kwong, Y. L.
    HONG KONG JOURNAL OF RADIOLOGY, 2011, 14 (04): : S63 - S67
  • [25] Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study
    Davies, Andrew
    Merli, Francesco
    Mihaljevic, Biljana
    Siritanaratkul, Noppadol
    Solal-Celigny, Phillippe
    Barrett, Martin
    Berge, Claude
    Bittner, Beate
    Boehnke, Axel
    McIntyre, Christine
    MacDonald, David
    LANCET ONCOLOGY, 2014, 15 (03): : 343 - 352
  • [26] Rituximab With or Without Bevacizumab for the Treatment of Patients With Relapsed Follicular Lymphoma
    Hainsworth, John D.
    Greco, F. Anthony
    Raefsky, Eric L.
    Thompson, Dana S.
    Lunin, Scott
    Reeves, James, Jr.
    White, Lynn
    Quinn, Raven
    DeBusk, Laura M.
    Flinn, Ian W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (04): : 277 - 283
  • [27] Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
    Franz Buchegger
    Oliver W Press
    EJNMMI Research, 1
  • [28] Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma
    Vicente, Fatima de la Cruz
    Cruz, Estrella Carrillo
    Rodriguez, Maria Sole
    Niebla, Ana Marin
    Herranz, Eduardo Rios
    Galiana, Maria Luz Martino
    Gonzalez, Jose Falantes
    Cuadrado, Isabel Montero
    Campos, Jose Gonzalez
    Tocino, Ildefonso Espigado
    Perez-Simon, Jose A.
    BLOOD, 2013, 122 (21)
  • [29] TRANSFORMED FOLLICULAR LYMPHOMA TREATMENT OUTCOME DURING THE RITUXIMAB ERA
    Elhassadi, E.
    Flavin, R.
    Browne, P.
    Hayden, P.
    Higgins, L.
    Vanderberghe, E.
    HAEMATOLOGICA, 2014, 99 : 706 - 706
  • [30] Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab
    Ferrer A.
    López-Guillermo A.
    Montoto S.
    Estrach T.
    Colomo L.
    Montserrat E.
    Annals of Hematology, 2001, 80 (8) : 479 - 481
12345